Compound information
- Natural Products
- ZC685339
- Molecular Formula
- C21H27N3O5S
- Molecular Weight
- 433.167141964 g/mol
- Structure
-
- IUPAC Name
- 1-[4-[4-(4-acetylphenyl)sulfonylpiperazine-1-carbonyl]-1-piperidyl]prop-2-en-1-one
- InChI
- InChI=1S/C21H27N3O5S/c1-3-20(26)22-10-8-18(9-11-22)21(27)23-12-14-24(15-13-23)30(28,29)19-6-4-17(5-7-19)16(2)25/h3-7,18H,1,8-15H2,2H3
- InChI Key
- IBVRWIWOWSZNRW-UHFFFAOYSA-N
- SMILES
- C=CC(=O)N1CCC(C(=O)N2CCN(S(=O)(=O)c3ccc(C(C)=O)cc3)CC2)CC1
- Source
- ZINC001875369324
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 95.07 Å2 | LogP | 0.538 |
LogS | -2.853 | LogD | 1.188 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.027 | Pgp substrate | 0.99 |
HIA | 0.966 | F20 % | 0.991 |
F30 % | 0.021 | Caco-2 | -4.495 |
MDCK | -4.899 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.842 | PPB | 74.592 |
VD | 0.278 | Fu | 1.045 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.328 |
CYP2A6 substrate | 0.338 | CYP2B6 substrate | 0.556 |
CYP2C19 inhibitor | 0.211 | CYP2C19 substrate | 0.66 |
CYP2C8 substrate | 0.579 | CYP2C9 inhibitor | 0.233 |
CYP2C9 substrate | 0.754 | CYP2D6 inhibitor | 0.007 |
CYP2D6 substrate | 0.696 | CYP2E1 substrate | 0.369 |
CYP3A4 inhibitor | 0.049 | CYP3A4 substrate | 0.993 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.24 | CL | 2.359 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.083 | Hepatotoxicity | 0.94 |
Mutagenicity | 0.334 | Rat Oral Acute Toxicity | 0.431 |
FDAMDD | 0.568 | Skin Sensitization | 0.123 |
Carcinogenicity | 0.05 | Eye Corrosion | 0.005 |
Eye Irritation | 0.39 | Respiratory Toxicity | 0.013 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.521 | IGC50 | 2.716 |
LC50FM | -16.961 | LC50DM | 1.322 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.143 | NR-AR-LBD | 0.487 |
NR-AhR | 0.018 | NR-Aromatase | 0.015 |
NR-ER | 0.282 | NR-ER-LBD | 0.503 |
NR-PPAR-gamma | 0.277 | SR-ARE | 0.797 |
SR-ATAD5 | 0.366 | SR-HSE | 0.128 |
SR-MMP | 0.011 | SR-p53 | 0.08 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.